While many medications prescribed for chronic conditions are covered by insurance, weight-loss drugs are a different story
Both trials (NCT03887455 and NCT01760005) had a overall low risk of bias [43, 53, 83, 84]
Prevention starts with regular health checks and PSA screenings
This makes it useful beyond specific injury applications patients with chronic inflammation, autoimmune conditions, or post-intensive-exercise inflammation report meaningful reductions in systemic inflammatory markers
Real labs have professional websites with contact information
Betting on a widespread GLP-1 adoption, some private equity investors are practicing an investor version of the Ozempic diet and are refraining from investing in consumer companies (such as snackmakers, alcohol brands, or restaurant chains) that could be negatively impacted by the GLP-1 boom, believing that profits will get squeezed as GLP-1 users no longer crave them and/or obesity rates fall